Search results
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 day agoAstraZeneca AZN will report first-quarter 2024 results on Apr 25, before market open. In the last...
Analysts Set AstraZeneca PLC (NASDAQ:AZN) Price Target at $80.00
ETF DAILY NEWS· 23 hours agoShares of AstraZeneca PLC (NASDAQ:AZN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six brokerages that are currently covering the ...
AstraZeneca confirms strong vaccine protection after US rift
AOL· 20 hours agoAstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional...
A University of Oxford researcher is testing a revolutionary vaccine to prevent the onset of lung...
Fortune via Yahoo Finance· 9 hours agoBlagden is part of the research team working on LungVax, a world-first attempt to prevent lung...
ANGLE partners with AstraZeneca in groundbreaking oncology contract
Proactive Investors· 13 hours agoANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive Andrew Newland joins Proactive's Stephen Gunnion...
ANGLE shares jump 30% on AstraZeneca tie-up
Proactive Investors· 12 hours agoANGLE PLC (AIM:AGL, OTCQX:ANPCY) shares jumped 30% following the announcement of a strategic partnership with AstraZeneca PLC (LSE:AZN) that aims to...
With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Given the large stake in the stock by institutions,AstraZeneca's stock price might be...
Angle Inks Assay Development Deal with AstraZeneca
GenomeWeb News· 10 hours agoCirculating tumor cell (CTC) assay developer Angle said Wednesday that it has signed a supplier agreement with AstraZeneca to develop and validate a method for the detection ...
Greenleaf Trust Sells 1,500 Shares of AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 4 days agoGreenleaf Trust trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.1% during the 4th quarter, according to its most recent Form 13F filing with ...
AstraZeneca: What The Market's Missing (NASDAQ:AZN)
Seeking Alpha· 16 hours agoAnalyst’s Disclosure: I/we have a beneficial long position in the shares of AZN either through stock ownership, options, or other derivatives. All...
